Patent application number | Description | Published |
20080236990 | Method for Identifying Counterfeit Banknotes - A method for identifying suspected counterfeit and/or counterfeit banknotes paid into an automatic teller machine, wherein banknotes to be paid in are checked for authenticity on the basis of data from a sensor device. The identification is achieved by linking data from the sensor device concerning the suspected counterfeit and/or counterfeit banknotes to an identity of a payer. The method also includes storing the data concerning the suspected counterfeit and/or counterfeit banknotes and the identity of the payer, and generating checking data for the suspected counterfeit and/or counterfeit banknotes by means of the sensor device or a sensor device similar to the sensor device. The checking data are generated by the sensor device for one or more possible positions of the suspected counterfeit and/or counterfeit banknotes, comparing the checking data with the stored data concerning the suspected counterfeit and/or counterfeit banknotes and determining the data of the suspected counterfeit and/or counterfeit banknote which has the closest agreement with the respective checking data. The method further includes identifying the respective suspected counterfeit and/or counterfeit banknote by means of the identity of the payer, which is linked to the data concerning the suspected counterfeit and/or counterfeit banknote with the closest agreement. | 10-02-2008 |
20080283589 | Method for Identifying Banknotes Origin - The invention relates to a method for verifying the origin of bank notes from an automatic teller. | 11-20-2008 |
20100128934 | METHOD AND DEVICE FOR TESTING VALUE DOCUMENTS - The invention relates to a method and apparatus for recognizing forged value documents, for example composed forgeries which are assembled from parts of different value documents. In the inventive method, the signal intensity of a measuring signal is determined at a plurality of measuring points on a value document. For one or more selected groups of measuring points which are disposed in particular along certain directions on the value document there are determined gradient values of the signal intensities. The gradient values of a group are subsequently linked to form a connection strength of the group which provides a quantitative statement about the extent to which a large gradient value exists consistently within the particular group. From a relatively great connection strength there can be inferred the presence of a separating line in the area of the selected group of measuring points. | 05-27-2010 |
20110199649 | METHOD AND DEVICE FOR PROCESSING VALUE DOCUMENTS - The invention relates to an apparatus and a method for processing value documents. A value document is input to the input opening of an apparatus for value-document processing and transported using a transport system of the apparatus to an image sensor which senses a partial image of the value document. A contour of the front partial area is ascertained from the sensed partial image and checked. If the check of the contour of the front partial area yields a fault, the value document is rejected. Faulty or faultily transported value documents can thus be recognized and transported back to the input opening at a very early time. | 08-18-2011 |
20140147030 | SENSOR FOR CHECKING VALUE DOCUMENTS - A sensor for checking value documents, an apparatus with the sensor, and a method for operating the sensor. Neither the software that the sensor executes for checking the value documents nor the adaptation data that the sensor employs for checking the value documents are stored permanently in the sensor itself. The sensor is set up for the software as well as the adaptation data to be loaded into the sensor from outside the sensor. The sensor can be employed for checking value documents only when a data carrier is connected to the sensor, and the data carrier has license data stored thereon through which a license for the employment of the software and/or of the adaptation data is supplied to the sensor. | 05-29-2014 |
Patent application number | Description | Published |
20090054588 | Fluoride-modified additive for cementitious products, process for its preparation and use thereof - A fluoromodified admixture containing isocyanate and urethane and/or urea groups is described. Surprisingly, it has been found that the fluoromodified admixture according to the invention is outstandingly suitable even at a very low dosage for the permanent hydrophobic and/or oleophobic and/or dirt-repellent in-bulk finishing of products based on inorganic or hydraulic or mineral binders, without the fundamental property profile (e.g. compressive and flexural tensile strengths) of these products being substantially influenced. Moreover, it was not to be foreseen that in the case of the products treated with the fluoromodified admixtures according to the invention (e.g. hardened building material compositions) a markedly lower water absorption (avoidance of frost damage and corrosion) and a suppression of bleeding on the surfaces (avoidance of visual impairment) are to be observed. Furthermore, it could not be expected that in spite of the high fluorine modification an adequate self-dispersibility is afforded. | 02-26-2009 |
20090198000 | Liquid fluorine-containing and two-component compositions for the surface treatment of mineral and non-mineral substrates - Fluorine-containing and two-component compositions exhibit improved surface properties for the permanent oil- and water-repellent surface treatment or modification of mineral and non-mineral substrates for various fields of application. At a simultaneously reduced fluorine content, these compositions have considerably improved application properties and, in combination with suitable stabilizing components and hydrophilic silane components, they exhibit excellent hydrophobic, oleophobic and soil-repellent properties, having overall excellent storage stability. | 08-06-2009 |
20090240004 | FUNCTIONALIZED POLYURETHANE RESIN, METHOD FOR THE PRODUCTION THEREOF, AND USE THEREOF - Disclosed is a functionalized polyurethane resin containing a binder component, a hardener component and, optionally, a formulation component. The binder component consists essentially of urethane dispersions with defined structural components which, in turn, consist of special reaction products. Such polyurethane resins are used for the production of fluorine-modified polyurethane coatings and generally in construction or industrial applications for the permanent oil-, water- and dirt-resistant coating of mineral and non-mineral surfaces on the basis of, for example, hydraulically setting components. | 09-24-2009 |
20100285311 | Dual component (aqueous) hybrid reactive resin system, method for production and use thereof - A dual component (aqueous) hybrid reactive system obtained by a) the production of an epoxy-functional (aqueous) binding agent component (I) with an epoxide equivalent of 100 to 12,500 g/eq, and average molecular mass of 200 to 25,000 Daltons and a viscosity of 1,000 to 15,000 mPas 920° C., Brookfield) and b) the production of a (latent) amino-functional hardener component (II). | 11-11-2010 |
20100324205 | FLUID, FLUORINE-CONTAINING AND SINGLE-COMPONENT COMPOSITION - Novel fluorine-containing compositions which have improved surface properties for the permanent oil- and water-repellent surface treatment or modification of mineral and nonmineral substrates for various fields of application and are present in single-component form are claimed. These compositions have, at a reduced fluorine content, significantly improved use properties and they can, in combination with suitable stabilizing components and hydrophilic silane components, be additionally optimized in terms of their hydrophobic, oleophobic and dirt-repellent properties, and they have excellent storage stability. | 12-23-2010 |
20120222863 | ALKANESULFONIC ACID MICROCAPSULES AND USE THEREOF IN DEEP WELLS - Alkanesulfonic acid microcapsules and the use thereof as an additive for acidizing applications in carbonatic rock formations, especially for increasing the permeability of underground carbonatic mineral oil- and/or natural gas-bearing and/or hydrothermal rock formations and for dissolving carbonatic and/or carbonate-containing impurities in the production of mineral oil and/or natural gas or geothermal power generation are described. Additionally described is an acidic formulation comprising the inventive microcapsules and the use thereof for the aforementioned purpose, and a corresponding process. | 09-06-2012 |
20140235760 | POWDER COMPOSITION FOR RAPID SUSPENSION - The invention relates to a pulverulent composition which can be produced by bringing a powder which comprises at least one inorganic binder into contact with from 0.01 to 10% by weight, based on the total mass of the composition, of a liquid component comprising at least one copolymer which can be obtained by polymerization of a mixture of monomers comprising (I) at least one ethylenically unsaturated monomer which comprises at least one radical selected from the group consisting of carboxylic acid, carboxylic acid salt, carboxylic esters, carboxamide, carboxylic anhydride and carboximide and (II) at least one ethylenically unsaturated monomer having a polyalkylene oxide radical, where the liquid component contains at least 1% by weight of the at least one copolymer and at least 30% by weight of an organic solvent. Furthermore, a process for producing the liquid component, the use thereof and also specific copolymers are disclosed. | 08-21-2014 |
20150225339 | FLUORINATED POLYMERIZABLE COMPOUND - The invention relates to a polymerizable compound of formula (I), where R | 08-13-2015 |
20150240085 | Fluorine-Containing Nonaqueous Coating Material Composition, Coating Methods, And The Use Of The Coating Material Composition - The present invention provides nonaqueous coating material compositions comprising 30% to 80% by weight of at least one poly(meth)acrylate (A), 20% to 70% by weight of one or more polyisocyanate group-containing compounds (B), and one or more catalysts (D), the weight percentages being based in each case on the binder content of (A) and (B), respectively, and the sum of the weight fractions of (A) plus (B) being in each case 100% by weight, | 08-27-2015 |
Patent application number | Description | Published |
20090053213 | Anti-Gm-Csf Antibodies and Uses Therefor - The present invention provides recombinant antigen-binding regions, antibodies and functional fragments thereof that are specific for GM-CSF, which plays an integral role in various disorders or conditions. These antibodies, accordingly, can be used to treat, for example, inflammatory diseases such as rheumatoid arthritis. Antibodies of the invention also can be used in the diagnostics field, as well as for further investigating the role of GM-CSF in the progression of various disorders. The invention also provides nucleic acid sequences encoding the foregoing antibodies, vectors containing the same, pharmaceutical compositions and kits with instructions for use. | 02-26-2009 |
20100291078 | Proteinaceous binding molecules comprising purification tags or inert variable domains - The present invention provides proteinaceous binding molecules, in particular antibodies, having at least two variable domains. One variable domain binds to a target molecule of interest. At least one other variable domain comprises a purification tag suitable for purification of said proteinaceous binding molecule. The purification tag enables the convenient purification of the proteinaceous binding molecule with monovalent binding properties against the target molecule. | 11-18-2010 |
20110045000 | Anti-GM-CSF antibodies and uses therefor - The present invention provides recombinant antigen-binding regions, antibodies and functional fragments thereof that are specific for GM-CSF, which plays an integral role in various disorders or conditions. These antibodies, accordingly, can be used to treat, for example, inflammatory diseases such as rheumatoid arthritis. Antibodies of the invention also can be used in the diagnostics field, as well as for further investigating the role of GM-CSF in the progression of various disorders. The invention also provides nucleic acid sequences encoding the foregoing antibodies, vectors containing the same, pharmaceutical compositions and kits with instructions for use. | 02-24-2011 |
20110110944 | ANTI-ALK1 ANTIBODIES AND USES THEREOF - The present invention provides recombinant antigen-binding regions and antibodies and functional fragments containing such antigen-binding regions that are specific for AIk1, which plays an integral role in various disorders or conditions, such as cancer and macular degeneration. These antibodies, accordingly, can be used to treat these and other disorders and conditions. Antibodies of the invention also can be used in the diagnostics field, as well as for further investigating the role of AIk1 in the progression of disorders associated with pathogenic angiogenesis. The invention also provides nucleic acid sequences encoding the foregoing antibodies, vectors containing the same, pharmaceutical compositions and kits with instructions for use. | 05-12-2011 |
20140205608 | Use of c-Fms antagonists - The present invention relates generally to a method for the treatment and/or prophylaxis of osteoarthritis (OA) and/or pain. In accordance with the present invention, an antagonist of c-Fms is effective in the treatment of osteoarthritis and/or pain. An antagonist of M-CSF includes, but is not limited to, an antibody that is specific for M-CSF, IL-34 or c-Fms. | 07-24-2014 |
20140255427 | COMBINATION THERAPY WITH AN ANTI - CD19 ANTIBODY AND A NITROGEN MUSTARD - The present disclosure describes a pharmaceutical combination of an anti-CD19 antibody and a nitrogen mustard for the treatment of non-Hodgkin's lymphoma, chronic lymphocytic leukemia and/or acute lymphoblastic leukemia. | 09-11-2014 |
Patent application number | Description | Published |
20090081207 | High affinity human and humanized anti-alpha5beta1 integrin function blocking antibodies with reduced immunogenicity - The present invention relates to recombinant human or humanized polypeptides which bind to α5β1 integrin with high affinity and blocking function. Further, diagnostic and pharmaceutic applications of the potypeptides are disclosed. | 03-26-2009 |
20090137002 | ANTI EPHB4 ANTIBODIES AND ANTIBODY FRAGMENTS - The invention concerns antibodies and antibody fragments, specifically recognising the EphB4 receptor comprising heavy chains and light chain, comprising light and heavy CDR's, and their use as medicament for the treatment of pathological angiogenesis, in particular cancer therapy. | 05-28-2009 |
20110027268 | ANTI-MESOTHELIN ANTIBODIES AND USES THEREOF - The present invention provides recombinant antigen-binding regions and antibodies and functional fragments containing such antigen-binding regions that are specific for the membrane-anchored, 4O.kDa mesothelin polypeptide, which is overexpressed in several tumors, such as pancreatic and ovarian tumors, mesothelioma and lung cancer cells. These antibodies, accordingly, can be used to treat these and other disorders and conditions. Antibodies of the invention also can be used in the diagnostics field, as well as for further investigating the role of mesothelin in the progression of disorders associated with cancer. The invention also provides nucleic acid sequences encoding the foregoing antibodies, vectors containing the same, pharmaceutical compositions and kits with instructions for use. | 02-03-2011 |
20120076782 | GENERATION AND PROFILING OF FULLY HUMAN HUCAL GOLD.RTM.-DERIVED THERAPEUTIC ANTIBODIES SPECIFIC FOR HUMAN CD38 - The present invention provides novel methods for using recombinant antigen-binding regions and antibodies and functional fragments containing such antigen-binding regions that are specific for CD38, which plays an integral role in various disorders or conditions. These methods take advantage of newly discovered antibodies and surprising properties of such antibodies, such as the ability to bind CD38 of minipig origin and the ability to induce, by cross-linking, specific killing of cells that express CD38. These antibodies as well as the novel methods for using those antibodies can be used to treat, for example, hematological malignancies such as multiple myeloma. | 03-29-2012 |
20140234298 | THERAPEUTIC COMBINATIONS OF ANTI-CD20 AND ANTI-GM-CSF ANTIBODIES AND USES THEREOF - The present disclosure describes a pharmaceutical combination of an anti-CD20 antibody and an anti-GM-CSF antibody. Said combinations are highly efficacious in the treatment of B cell malignancies and inflammatory disorders. | 08-21-2014 |